This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Pfizer Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovations of Yoshihisa Murata
Introduction
Yoshihisa Murata is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of sodium channel modulators. His work has implications for the treatment of various disorders, including pain management.
Latest Patents
Murata holds a patent for his invention titled "(4-phenylimidazol-2-yl) ethylamine derivatives useful as sodium channel modulators." This invention focuses on imidazole derivatives and their applications in medicine. The patent describes compositions containing these derivatives, processes for their preparation, and intermediates used in such processes. Specifically, the invention relates to a new imidazole Na1.8 modulator, which is beneficial in treating a wide range of disorders, particularly pain. He has 1 patent to his name.
Career Highlights
Yoshihisa Murata is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his research.
Collaborations
One of his notable coworkers is Sharanjeet Kaur Bagal, with whom he has likely collaborated on various projects within the pharmaceutical domain.
Conclusion
Yoshihisa Murata's innovative work in the field of medicinal chemistry exemplifies the importance of research in developing new treatments for pain and other disorders. His contributions continue to influence the pharmaceutical industry and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
